Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-30

FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for hydroxyzine hydrochloride by Teva Pharmaceuticals USA, Inc., under ANDA088617.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROXYZINE HYDROCHLORIDE (Hydroxyzine hydrochloride)

Snippet

SUPPL AP for HYDROXYZINE HYDROCHLORIDE (HYDROXYZINE HYDROCHLORIDE)